ESC Premium Access

The impact of residual mitral valve regurgitation on outcome after MitraClip therapy

Congress Presentation

About the speaker

Doctor Daniel Reichart

Ludwig-Maximilians University, Munich (Germany)
0 follower

5 more presentations in this session

Safety and feasibility of an early ambulation protocol after transfemoral transcatheter aortic valve implantation: results of the early mobilisation after TF-TAVI (MobiTAVI) trial

Speaker: Mr J. Vendrik (Amsterdam, NL)


Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using standardized new european definitions, a multicenter study

Speaker: Doctor A. Sokoloff (Rouen, FR)


6 month follow up results from the european transcatheter tricuspid valve repair multicenter trial

Speaker: Assistant Professor R. Von Bardeleben (Mainz, DE)


Up to two-year outcomes from the multicenter CE trial of transcatheter mitral valve repair in patients with functional mitral regurgitation

Speaker: Doctor A. Latib (New York, US)


Panel discussion.


Access the full session

Advances in structural heart interventions

Speakers: Doctor D. Reichart, Mr J. Vendrik, Doctor A. Sokoloff, Assistant Professor R. Von Bardeleben, Doctor A. Latib

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb